About this trial
Chronic obstructive pulmonary disease (COPD) is a disease that continues to generate a great deal of research and this research must continue, both because it is not completely curable and because of the large patient population. The importance and benefits of exercise training in COPD patients are clear. One of the most preferred types of exercise training is the so-called aerobic exercise training, which typically takes the form of walking. A typical walking training does not use a slope or may include an uphill slope. However, recently there have been publications about downhill walking and its benefits in COPD. Walking on a level, uphill, and downhill slope may have the potential to result in different gains by using different muscle groups more. Therefore, this study aimed to compare the effects of walking training on exercise capacity, respiratory functions, muscle strength, and functional status in COPD patients with three different slope types: level, uphill, and downhill.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being diagnosed with COPD (A, B, E groups according to GOLD assessment)
Ambulate on your own
Not having any contraindications for exercise
To be mentally appropriate (score 24 points and above in the mini mental test)
Disqualifiers
Being in GOLD 4 stage in spirometric evaluation
Presence of hypoxemia
Participation in another pulmonary rehabilitation program within the last 6 months
Having an exacerbation in the last 1 month
Trial design
Parallel
Treatments tested in this trial
Downhill walking training
Other interventionFor 8 weeks, downhill walking training will be done 2 times a week at a slope of -10 degrees.
Level walking training
Other interventionFor 8 weeks, level walking training will be done 2 times a week at a slope of 0 degrees.
Uphill walking training
Other interventionFor 8 weeks, uphill walking training will be done 2 times a week at a slope of +10 degrees.
Treatment groups
Trial outcomes
Primary outcomes
6 Minutes Walking Distance (6MWD)
6 MWD means the distance traveled in 6 MWT. Its unit is meters.
Spirometric measurements (Forced vital capacity)
It is used to evaluate respiratory functions. It is evaluated with a spirometer. Forced vital capacity (FVC): the maximum amount of air that can be forcibly exhaled from the lungs after fully inhaling. It can be recorded in percentages or liters.
Spirometric measurements (First second forced expiratory volume)
It is used to evaluate respiratory functions. It is evaluated with a spirometer. First-second forced expiratory volume (FEV1): the amount of air that can be exhaled with force in 1 second. It can be recorded in percentages or liters.
Spirometric measurements (FEV1/FVC ratio)
It is used to evaluate respiratory functions. It is evaluated with a spirometer. It is calculated by dividing FEV1 by FVC. It is expressed as a percentage.
Secondary outcomes
Dyspnea
It will be reported by the participant using the modified borg scale (between 0-10 points). On this scale, 0 is the lowest score and means absent, while 10 is the highest score and indicates that the condition is most severe.
Fatigue
It will be reported by the participant using the modified borg scale (between 0-10 points).On this scale, 0 is the lowest score and means absent, while 10 is the highest score and indicates that the condition is most severe.
Level of exertion
It will be reported by the participant using the modified borg scale (between 0-10 points). On this scale, 0 is the lowest score and means absent, while 10 is the highest score and indicates that the condition is most severe.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Acibadem University
Lead sponsor
Bezmialem Vakif University
Collaborator